Endothelial progenitor cells for diagnosis and prognosis in cardiovascular disease

Stem Cells International

Volumn 2016, Issue , 2016, Pages

  Aragona, Caterina Oriana ^a   Imbalzano, Egidio ^a   Mamone, Federica ^a   Cairo, Valentina ^a   Lo Gullo, Alberto ^a   D'Ascola, Angela ^b   Sardo, Maria Adriana ^a   Scuruchi, Michele ^b   Basile, Giorgio ^a   Saitta, Antonino ^a   Mandraffino, Giuseppe ^a  

^a UNIVERSITY OF MESSINA   (Italy)

^b UNIVERSITY OF MESSINA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; REACTIVE OXYGEN METABOLITE;

ACUTE HEART INFARCTION; AGING; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CELL COUNT; CELL PROLIFERATION; CLINICAL EVALUATION; CORONARY ARTERY DISEASE; DYSLIPIDEMIA; ENDOTHELIAL PROGENITOR CELL; HUMAN; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK FACTOR; SMOKING HABIT; STEM CELL TRANSPLANTATION;

EID: 84956894314     PISSN: None     EISSN: 16879678     Source Type: Journal    
DOI: 10.1155/2016/8043792     Document Type: Review

References (116)

1. T. Asahara, T. Murohara, A. Sullivan et al., "Isolation of putative progenitor endothelial cells for angiogenesis, " Science, vol. 275, no. 5302, pp. 964-967, 1997.
2. N. Werner, J. Priller, U. Laufs et al., "Bone marrow-derived progenitor cells modulate vascular reendothelialization and neointimal formation: effect of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition, " Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 22, no. 10, pp. 1567-1572, 2002.
3. O. M. Tepper, J. M. Capla, R. D. Galiano et al., "Adult vasculogenesis occurs through in situ recruitment, proliferation, and tubulization of circulating bone marrow-derived cells, " Blood, vol. 105, no. 3, pp. 1068-1077, 2005.
4. G. P. Fadini, C. Agostini, S. Sartore, and A. Avogaro, "Endothelial progenitor cells in the natural history of atherosclerosis, " Atherosclerosis, vol. 194, no. 1, pp. 46-54, 2007.
5. M. Peichev, A. J. Naiyer, D. Pereira et al., "Expression of VEGFR 2 and AC133 by circulating human CD34+ cells identifies a population of functional endothelial precursors, " Blood, vol. 95, no. 3, pp. 952-958, 2000.
6. N. Quirici, D. Soligo, L. Caneva, F. Servida, P. Bossolasco, and G. L. Deliliers, "Differentiation and expansion of endothelial cells from human bone marrow CD133+ cells, " British Journal of Haematology, vol. 115, no. 1, pp. 186-194, 2001.
7. C. Kalka, H. Masuda, T. Takahashi et al., "Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization, " Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 7, pp. 3422-3427, 2000.
8. M. Vasa, S. Fichtlscherer, A. Aicher et al., "Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease, " Circulation Research, vol. 89, no. 1, pp. E1-E7, 2001.
9. J. M. Hill, G. Zalos, J. P. J. Halcox et al., "Circulating endothelial progenitor cells, vascular function, and cardiovascular risk, "The New England Journal of Medicine, vol. 348, no. 7, pp. 593-600, 2003.
10. M. C. Yoder, L. E. Mead, D. Prater et al., "Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/ progenitor cell principals, " Blood, vol. 109, no. 5, pp. 1801-1809, 2007.
11. D. A. Ingram, L. E. Mead, H. Tanaka et al., "Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood, " Blood, vol. 104, no. 9, pp. 2752-2760, 2004.
12. D. P. Basile and M. C. Yoder, "Circulating and tissue resident endothelial progenitor cells, " Journal of Cellular Physiology, vol. 229, no. 1, pp. 10-16, 2014.
13. M. Steinmetz, G. Nickenig, and N. Werner, "Endothelialregenerating cells: an expanding universe, " Hypertension, vol. 55, no. 3, pp. 593-599, 2010.
14. F. Timmermans, J. Plum, M. C. Yoder, D. A. Ingram, B. Van de Kerckhove, and J. Case, "Endothelial progenitor cells: identity defined?" Journal of Cellular andMolecularMedicine, vol. 13, no. 1, pp. 87-102, 2009.
15. M. C. Yoder, "Endothelial progenitor cell: a blood cell by many other names may serve similar functions, " Journal of Molecular Medicine, vol. 91, no. 3, pp. 285-295, 2013.
16. M. R. Richardson and M. C. Yoder, "Endothelial progenitor cells: quo vadis?" Journal of Molecular and Cellular Cardiology, vol. 50, no. 2, pp. 266-272, 2011.
17. K. K. Hirschi, D. A. Ingram, and M. C. Yoder, "Assessing identity, phenotype, and fate of endothelial progenitor cells, " Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 28, no. 9, pp. 1584-1595, 2008.
18. H. C. de Boer, M. M. Hovens, A. M. van Oeveren-Rietdijk et al., "Human CD34+/KDR+ cells are generated from circulating CD34+ cells after immobilization on activated platelets, " Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 31, no. 2, pp. 408-415, 2011.
19. G. P. Fadini, S. de Kreutzenberg, C. Agostini et al., "Low CD34+ cell count and metabolic syndrome synergistically increase the risk of adverse outcomes, "Atherosclerosis, vol. 207, no. 1, pp. 213-219, 2009.
20. A. Lo Gullo, G. Mandraffino, E. Imbalzano et al., "Toll-like receptor 3 and interleukin 1beta expression in CD34+ cells from patients with rheumatoid arthritis: association with inflammation and vascular involvement, " Clinical and Experimental Rheumatology, vol. 32, no. 6, pp. 922-929, 2014.
21. T. Asahara, A. Kawamoto, and H. Masuda, "Concise review: circulating endothelial progenitor cells for vascular medicine, " Stem Cells, vol. 29, no. 11, pp. 1650-1655, 2011.
22. L. E. Sidney, M. J. Branch, S. E. Dunphy, H. S. Dua, and A. Hopkinson, "Concise review: evidence for CD34 as a common marker for diverse progenitors, " Stem Cells, vol. 32, no. 6, pp. 1380-1389, 2014.
23. G. P. Fadini, D. Losordo, and S. Dimmeler, "Critical reevaluation of endothelial progenitor cell phenotypes for therapeutic and diagnostic use, " Circulation Research, vol. 110, no. 4, pp. 624-637, 2012.
24. H. Chao and K. K. Hirschi, "Hemato-vascular origins of endothelial progenitor cells?" Microvascular Research, vol. 79, no. 3, pp. 169-173, 2010.
25. N. Werner, S. Kosiol, T. Schiegl et al., "Circulating endothelial progenitor cells and cardiovascular outcomes, " The New England Journal of Medicine, vol. 353, no. 10, pp. 999-1007, 2005.
26. J. A. Ambrose and R. S. Barua, "The pathophysiology of cigarette smoking and cardiovascular disease: an update, " Journal of the American College of Cardiology, vol. 43, no. 10, pp. 1731-1737, 2004.
27. W. Droge, "Free radicals in the physiological control of cell function, " Physiological Reviews, vol. 82, no. 1, pp. 47-95, 2002.
28. R. S. Barua, J. A. Ambrose, S. Srivastava, M. C. DeVoe, and L.-J. Eales-Reynolds, "Reactive oxygen species are involved in smoking-induced dysfunction of nitric oxide biosynthesis and upregulation of endothelial nitric oxide synthase: an in vitro demonstration in human coronary artery endothelial cells, " Circulation, vol. 107, no. 18, pp. 2342-2347, 2003.
29. S. Nakamura, M. Kimura, C. Goto et al., "Cigarette smoking abolishes ischemic preconditioning-induced augmentation of endothelium-dependent vasodilation, " Hypertension, vol. 53, no. 4, pp. 674-681, 2009.
30. I. Edirisinghe, S.-R. Yang, H. Yao et al., "VEGFR-2 inhibition augments cigarette smoke-induced oxidative stress and inflammatory responses leading to endothelial dysfunction, " The FASEB Journal, vol. 22, no. 7, pp. 2297-2310, 2008.
31. W.-S. Yue, M. Wang, G.-H. Yan et al., "Smoking is associated with depletion of circulating endothelial progenitor cells and elevated pulmonary artery systolic pressure in patients with coronary artery disease, " The American Journal of Cardiology, vol. 106, no. 9, pp. 1248-1254, 2010.
32. F. Mobarrez, L. Antoniewicz, J. A. Bosson, J. Kuhl, D. S. Pisetsky, and M. Lundback, "The effects of smoking on levels of endothelial progenitor cells and microparticles in the blood of healthy volunteers, " PLoS ONE, vol. 9, no. 2, Article ID e90314, 2014.
33. T. Kondo, M. Hayashi, K. Takeshita et al., "Smoking cessation rapidly increases circulating progenitor cells in peripheral blood in chronic smokers, " Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 24, no. 8, pp. 1442-1447, 2004.
34. S. E. Michaud, S. Dussault, P. Haddad, J. Groleau, and A. Rivard, "Circulating endothelial progenitor cells from healthy smokers exhibit impaired functional activities, " Atherosclerosis, vol. 187, no. 2, pp. 423-432, 2006.
35. E. Dernbach, C. Urbich, R. P. Brandes, W. K. Hofmann, A. M. Zeiher, and S. Dimmeler, "Antioxidative stress-associated genes in circulating progenitor cells: evidence for enhanced resistance against oxidative stress, " Blood, vol. 104, no. 12, pp. 3591-3597, 2004.
36. L. Rossig, C. Urbich, and S. Dimmeler, "Endothelial progenitor cells at work: not mature yet, but already stress-resistant, " Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 24, no. 11, pp. 1977-1979, 2004.
37. L. Gao and G. E. Mann, "Vascular NAD(P)H oxidase activation in diabetes: a double-edged sword in redox signalling, " Cardiovascular Research, vol. 82, no. 1, pp. 9-20, 2009.
38. G. Mandraffino, M. A. Sardo, S. Riggio et al., "Smoke exposure and circulating progenitor cells: evidence for modulation of antioxidant enzymes and cell count, " Clinical Biochemistry, vol. 43, no. 18, pp. 1436-1442, 2010.
39. J. Roncalli, F. Mouquet, C. Piot et al., "Intracoronary autologous mononucleated bonemarrow cell infusion for acutemyocardial infarction: results of the randomized multicenter BONAMI trial, " EuropeanHeart Journal, vol. 32, no. 14, pp. 1748-1757, 2011.
40. G. Lamirault, S. Susen, V. Forest et al., "Difference in mobilization of progenitor cells after myocardial infarction in smoking versus non-smoking patients: insights fromthe BONAMI trial, " Stem Cell Research andTherapy, vol. 4, no. 6, article 152, 2013.
41. S. Lewington, R. Clarke, N. Qizilbash, R. Peto, and R. Collins, "Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies, " The Lancet, vol. 360, no. 9349, pp. 1903-1913, 2002.
42. K. A. Britton, J. M. Gaziano, and L. Djousse, "Normal systolic blood pressure and risk of heart failure in US male physicians, " European Journal of Heart Failure, vol. 11, no. 12, pp. 1129-1134, 2009.
43. A. Oliveras, M. J. Soler, O. M. Martinez-Estrada et al., "Endothelial progenitor cells are reduced in refractory hypertension, " Journal ofHumanHypertension, vol. 22, no. 3, pp. 183-190, 2008.
44. E. Imbalzano, G. Mandraffino, R. Ceravolo, R. Di Stefano, and A. Saitta, "Renal denervation rapidly restores circulating proangiogenic hematopoietic cells in patients affected by drugresistant hypertension, " International Journal of Cardiology, vol. 173, no. 3, pp. 591-592, 2014.
45. O. J. MacEneaney, C. A. DeSouza, B. R. Weil et al., "Prehypertension and endothelial progenitor cell function, " Journal of Human Hypertension, vol. 25, no. 1, pp. 57-62, 2011.
46. P. Delva, M. Degan, P. Vallerio et al., "Endothelial progenitor cells in patients with essential hypertension, " Journal of Hypertension, vol. 25, no. 1, pp. 127-132, 2007.
47. G. Mandraffino, E. Imbalzano, M. A. Sardo et al., "Circulating progenitor cells in hypertensive patients with different degrees of cardiovascular involvement, " Journal of Human Hypertension, vol. 28, no. 9, pp. 543-550, 2014.
48. G. P. Fadini, D. Losordo, and S. Dimmeler, "Critical reevaluation of endothelial progenitor cell phenotypes for therapeutic and diagnostic use, " Circulation Research, vol. 110, no. 4, pp. 624-637, 2012.
49. G. P. Fadini, S. V. de Kreutzenberg, A. Coracina et al., "Circulating CD34+ cells, metabolic syndrome, and cardiovascular risk, " European Heart Journal, vol. 27, no. 18, pp. 2247-2255, 2006.
50. M. Brownlee, "The pathobiology of diabetic complications: a unifying mechanism, " Diabetes, vol. 54, no. 6, pp. 1615-1625, 2005.
51. C. J. M. Loomans, E. J. P. de Koning, F. J. T. Staal et al., "Endothelial progenitor cell dysfunction: a novel concept in the pathogenesis of vascular complications of type 1 diabetes, " Diabetes, vol. 53, no. 1, pp. 195-199, 2004.
52. T. Kusuyama, T. Omura, D. Nishiya et al., "Effects of treatment for diabetes mellitus on circulating vascular progenitor cells, " Journal of Pharmacological Sciences, vol. 102, no. 1, pp. 96-102, 2006.
53. C. G. Egan, R. Lavery, F. Caporali et al., "Generalised reduction of putative endothelial progenitors and CXCR4-positive peripheral blood cells in type 2 diabetes, " Diabetologia, vol. 51, no. 7, pp. 1296-1305, 2008.
54. G. P. Fadini, "Areappraisal of the role of circulating (progenitor) cells in the pathobiology of diabetic complications, " Diabetologia, vol. 57, no. 1, pp. 4-15, 2014.
55. M. F. Lombardo, P. Iacopino, M. Cuzzola et al., "Type 2 diabetes mellitus impairs the maturation of endothelial progenitor cells and increases the number of circulating endothelial cells in peripheral blood, " Cytometry Part A, vol. 81, no. 10, pp. 856-864, 2012.
56. V. Asnaghi, R. Lattanzio, G. Mazzolari et al., "Increased clonogenic potential of circulating endothelial progenitor cells in patients with type 1 diabetes and proliferative retinopathy, " Diabetologia, vol. 49, no. 5, pp. 1109-1111, 2006.
57. S. Brunner, F. Hoellerl, K. E. Schmid-Kubista et al., "Circulating angiopoietic cells and diabetic retinopathy in type 2 diabetes mellitus, with or without macrovascular disease, " Investigative Ophthalmology and Visual Science, vol. 52, no. 7, pp. 4655-4662, 2011.
58. J.-A. Kim, M. Montagnani, K. K. Kwang, and M. J. Quon, "Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms, " Circulation, vol. 113, no. 15, pp. 1888-1904, 2006.
59. Y.-F. Liao, L.-L. Chen, T.-S. Zeng et al., "Number of circulating endothelial progenitor cells as a marker of vascular endothelial function for type 2 diabetes, " Vascular Medicine, vol. 15, no. 4, pp. 279-285, 2010.
60. F. Pistrosch, K. Herbrig, U. Oelschlaegel et al., "PPARgammaagonist rosiglitazone increases number and migratory activity of cultured endothelial progenitor cells, " Atherosclerosis, vol. 183, no. 1, pp. 163-167, 2005.
61. R. M. Cubbon, M. B. Kahn, and S. B. Wheatcroft, "Effects of insulin resistance on endothelial progenitor cells and vascular repair, " Clinical Science, vol. 117, no. 5, pp. 173-190, 2009.
62. H. E. Thomas Jr., W. B. Kannel, T. R. Dawber, and P. M. McNamara, "Cholesterol-phospholipid ratio in the prediction of coronary heart disease. The Framingham study, " The New England Journal of Medicine, vol. 274, no. 13, pp. 701-705, 1966.
63. G. S. Berenson, S. R. Srinivasan, W. Bao, W. P. Newman III, R. E. Tracy, and W. A. Wattigney, "Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults, " The New England Journal of Medicine, vol. 338, no. 23, pp. 1650-1656, 1998.
64. R. Ross, "Atherosclerosis-an inflammatory disease, " The New England Journal of Medicine, vol. 340, no. 2, pp. 115-126, 1999.
65. J. Z. Chen, F. R. Zhang, Q. M. Tao, X. X. Wang, J. H. Zhu, and J. H. Zhu, "Number and activity of endothelial progenitor cells from peripheral blood in patients with hypercholesterolaemia, " Clinical Science, vol. 107, no. 3, pp. 273-280, 2004.
66. T. Imanishi, T. Hano, T. Sawamura, and I. Nishio, "Oxidized low-density lipoprotein induces endothelial progenitor cell senescence, leading to cellular dysfunction, " Clinical and Experimental Pharmacology and Physiology, vol. 31, no. 7, pp. 407-413, 2004.
67. T. Gordon, W. P. Castelli, M. C. Hjortland, W. B. Kannel, and T. R. Dawber, "High density lipoprotein as a protective factor against coronary heart disease. The Framingham study, " The American Journal of Medicine, vol. 62, no. 5, pp. 707-714, 1977.
68. F. Rossi, C. Bertone, F. Montanile et al., "HDL cholesterol is a strong determinant of endothelial progenitor cells in hypercholesterolemic subjects, "Microvascular Research, vol. 80, no. 2, pp. 274-279, 2010.
69. U. Landmesser, F. Bahlmann, M. Mueller et al., "Simvastatin versus ezetimibe: pleiotropic and lipid-lowering effects on endothelial function in humans, " Circulation, vol. 111, no. 18, pp. 2356-2363, 2005.
70. A. U. Ferrari, A. Radaelli, and M. Centola, "Invited review: aging and the cardiovascular system, " Journal of Applied Physiology, vol. 95, no. 6, pp. 2591-2597, 2003.
71. O. Yildiz, "Vascular smooth muscle and endothelial functions in aging, " Annals of the New York Academy of Sciences, vol. 1100, pp. 353-360, 2007.
72. G. Coppolino, G. Basile, D. Bolignano, V. N. Mauro, and M. Buemi, "Circulating endothelial progenitor cell mobilization in centenarians: a powerful source for extended renal life, " Journal of the American Geriatrics Society, vol. 55, no. 10, pp. 1693-1694, 2007.
73. P. J. Goldschmidt-Clermont and E. D. Peterson, "On the memory of a chronic illness, " Science of Aging Knowledge Environment, vol. 2003, no. 45, article re8, 2003.
74. S. Dimmeler and M. Vasa-Nicotera, "Aging of progenitor cells: limitation for regenerative capacity?" Journal of the American College of Cardiology, vol. 42, no. 12, pp. 2081-2082, 2003.
75. C. Heiss, S. Keymel, U. Niesler, J. Ziemann, M. Kelm, and C. Kalka, "Impaired progenitor cell activity in age-related endothelial dysfunction, " Journal of the American College of Cardiology, vol. 45, no. 9, pp. 1441-1448, 2005.
76. K. E. Jie, M. H. J. Goossens, O. van Oostrom, M. R. Lilien, and M. C. Verhaar, "Circulating endothelial progenitor cell levels are higher during childhood than in adult life, " Atherosclerosis, vol. 202, no. 2, pp. 345-347, 2009.
77. W. H. Xia, Z. Yang, S. Y. Xu et al., "Age-related decline in reendothelialization capacity of human endothelial progenitor cells is restored by shear stress, " Hypertension, vol. 59, no. 6, pp. 1225-1231, 2012.
78. G. Mandraffino, M. A. Sardo, S. Riggio et al., "Circulating progenitor cells and the elderly: a seven-year observational study, " Experimental Gerontology, vol. 47, no. 5, pp. 394-400, 2012.
79. C. Marin, R. Ramirez, J. Delgado-Lista et al., "Mediterranean diet reduces endothelial damage and improves the regenerative capacity of endothelium, " American Journal of Clinical Nutrition, vol. 93, no. 2, pp. 267-274, 2011.
80. C. Marin, J. Delgado-Lista, R. Ramirez et al., "Mediterranean diet reduces senescence-associated stress in endothelial cells, " Age, vol. 34, no. 6, pp. 1309-1316, 2012.
81. C. Heeschen, R. Lehmann, J. Honold et al., "Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease, " Circulation, vol. 109, no. 13, pp. 1615-1622, 2004.
82. J. George, E. Goldstein, S. Abashidze et al., "Circulating endothelial progenitor cells in patients with unstable angina: association with systemic inflammation, " European Heart Journal, vol. 25, no. 12, pp. 1003-1008, 2004.
83. S. Shintani, T. Murohara, H. Ikeda et al., "Mobilization of endothelial progenitor cells in patients with acute myocardial infarction, " Circulation, vol. 103, no. 23, pp. 2776-2779, 2001.
84. M. Massa, V. Rosti, M. Ferrario et al., "Increased circulating hematopoietic and endothelial progenitor cells in the early phase of acute myocardial infarction, " Blood, vol. 105, no. 1, pp. 199-206, 2005.
85. U. Ghani, A. Shuaib, A. Salam et al., "Endothelial progenitor cells during cerebrovascular disease, " Stroke, vol. 36, no. 1, pp. 151-153, 2005.
86. A. Taguchi, T. Matsuyama, H. Moriwaki et al., "Circulating CD34-positive cells provide an index of cerebrovascular function, " Circulation, vol. 109, no. 24, pp. 2972-2975, 2004.
87. H.-K. Yip, L.-T. Chang, W.-N. Chang et al., "Level and value of circulating endothelial progenitor cells in patients after acute ischemic stroke, " Stroke, vol. 39, no. 1, pp. 69-74, 2008.
88. T. Sobrino, O. Hurtado, M. A. Moro et al., "The increase of circulating endothelial progenitor cells after acute ischemic stroke is associated with good outcome, " Stroke, vol. 38, no. 10, pp. 2759-2764, 2007.
89. P. M. Ridker, N. Rifai, L. Rose, J. E. Buring, and N. R. Cook, "Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events, " The New England Journal of Medicine, vol. 347, no. 20, pp. 1557-1565, 2002.
90. P. M. Ridker, M. J. Stampfer, and N. Rifai, "Novel risk factors for systemic atherosclerosis: a comparison ofC-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease, " The Journal of the AmericanMedical Association, vol. 285, no. 19, pp. 2481-2485, 2001.
91. P. E. Szmitko, C.-H. Wang, R. D. Weisel, J. R. de Almeida, T. J. Anderson, and S. Verma, "New markers of inflammation and endothelial cell activation. Part I, " Circulation, vol. 108, no. 16, pp. 1917-1923, 2003.
92. R. Ruckerl, A. Peters, N. Khuseyinova et al., "Determinants of the acute-phase proteinC-reactive protein inmyocardial infarction survivors: the role of comorbidities and environmental factors, " Clinical Chemistry, vol. 55, no. 2, pp. 322-335, 2009.
93. S. Verma, M. A. Kuliszewski, S.-H. Li et al., "C-reactive protein attenuates endothelial progenitor cell survival, differentiation, and function: further evidence of a mechanistic link between C-reactive protein and cardiovascular disease, " Circulation, vol. 109, no. 17, pp. 2058-2067, 2004.
94. O. Nygard, S. E. Vollset, H. Refsum et al., "Total plasma homocysteine and cardiovascular risk profile. The Hordaland homocysteine study, " The Journal of the American Medical Association, vol. 274, no. 19, pp. 1526-1533, 1995.
95. J. Z. Chen, J. H. Zhu, X. X. Wang et al., "Effects of homocysteine on number and activity of endothelial progenitor cells from peripheral blood, " Journal ofMolecular and Cellular Cardiology, vol. 36, no. 2, pp. 233-239, 2004.
96. P. Bogdanski, E. Miller-Kasprzak, D. Pupek-Musialik et al., "Plasma total homocysteine is a determinant of carotid intimamedia thickness and circulating endothelial progenitor cells in patients with newly diagnosed hypertension, " Clinical Chemistry and LaboratoryMedicine, vol. 50, no. 6, pp. 1107-1113, 2012.
97. T. J. Wang, M. J. Pencina, S. L. Booth et al., "Vitamin D deficiency and risk of cardiovascular disease, " Circulation, vol. 117, no. 4, pp. 503-511, 2008.
98. B. Kestenbaum, R. Katz, I. de Boer et al., "Vitamin D, parathyroid hormone, and cardiovascular events among older adults, " Journal of theAmericanCollege of Cardiology, vol. 58, no. 14, pp. 1433-1441, 2011.
99. D. Challoumas, "Vitamin D supplementation and lipid profile: what does the best available evidence show?" Atherosclerosis, vol. 235, no. 1, pp. 130-139, 2014.
100. N. A. Mikirova, G. Belcaro, J. A. Jackson, and N. H. Riordan, "Vitamin D concentrations, endothelial progenitor cells, and cardiovascular risk factors, " Panminerva Medica, vol. 52, supplement 1, no. 2, pp. 81-87, 2010.
101. B. Assmus, V. Schachinger, C. Teupe et al., "Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI), " Circulation, vol. 106, no. 24, pp. 3009-3017, 2002.
102. D. M. Leistner, U. Fischer-Rasokat, J. Honold et al., "Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI): final 5-year results suggest long-term safety and efficacy, " Clinical Research in Cardiology, vol. 100, no. 10, pp. 925-934, 2011.
103. B. E. Strauer, M. Brehm, T. Zeus et al., "Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans, " Circulation, vol. 106, no. 15, pp. 1913-1918, 2002.
104. S. Janssens, C. Dubois, J. Bogaert et al., "Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial, "TheLancet, vol. 367, no. 9505, pp. 113-121, 2006.
105. V. Schachinger, B. Assmus, S. Erbs et al., "Intracoronary infusion of bone marrow-derived mononuclear cells abrogates adverse left ventricular remodelling post-acute myocardial infarction: insights from the reinfusion of enriched progenitor cells and infarct remodelling in acute myocardial infarction (REPAIR-AMI) trial, " European Journal of Heart Failure, vol. 11, no. 10, pp. 973-979, 2009.
106. G. P. Meyer, K. C. Wollert, J. Lotz et al., "Intracoronary bone marrow cell transfer after myocardial infarction: 5-year followup from the randomized-controlled BOOST trial, " European Heart Journal, vol. 30, no. 24, pp. 2978-2984, 2009.
107. A. Schaefer, C. Zwadlo, M. Fuchs et al., "Long-term effects of intracoronary bone marrow cell transfer on diastolic function in patients after acute myocardial infarction: 5-year results fromthe randomized-controlled BOOST trial-an echocardiographic study, " European Journal of Echocardiography, vol. 11, no. 2, pp. 165-171, 2010.
108. H. J. Duckers, S. Silber, R. de Winter et al., "Circulating endothelial progenitor cells predict angiographic and intravascular ultrasound outcome following percutaneous coronary interventions in the HEALING-II trial: evaluation of an endothelial progenitor cell capturing stent, " EuroIntervention, vol. 3, no. 1, pp. 67-75, 2007.
109. H. J. Duckers, T. Soullie, P. den Heijer et al., "Accelerated vascular repair following percutaneous coronary intervention by capture of endothelial progenitor cells promotes regression of neointimal growth at long term follow-up: final results of the Healing II trial using an endothelial progenitor cell capturing stent (Genous R stent), " EuroIntervention, vol. 3, no. 3, pp. 350-358, 2007.
110. J. Aoki, P. W. Serruys, H. Van Beusekom et al., "Endothelial progenitor cell capture by stents coated with antibody against CD34: the HEALING-FIM (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth-First in Man) registry, " Journal of the American College of Cardiology, vol. 45, no. 10, pp. 1574-1579, 2005.
111. M. A. Beijk, P. Damman, M. Klomp et al., "Twelve-month clinical outcomes after coronary stenting with the Genous Bio-engineered R Stent in patients with a bifurcation lesion: fromthe e-HEALING (Healthy Endothelial Accelerated Lining InhibitsNeointimalGrowth) registry, "CoronaryArteryDisease, vol. 23, no. 3, pp. 201-207, 2012.
112. S. Silber, P. Damman, M. Klomp et al., "Clinical results after coronary stenting with the Genous bio-engineered R stent: 12-month outcomes of the e-HEALING (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth) worldwide registry, " EuroIntervention, vol. 6, no. 7, pp. 819-825, 2011.
113. R. Compagna, B. Amato, S. Massa et al., "Cell therapy in patients with critical limb ischemia, " Stem Cells International, vol. 2015, Article ID 931420, 13 pages, 2015.
114. Z.-X. Wang, D. Li, J.-X. Cao et al., "Efficacy of autologous bone marrow mononuclear cell therapy in patients with peripheral arterial disease, " Journal of Atherosclerosis andThrombosis, vol. 21, no. 11, pp. 1183-1196, 2014.
115. C. Urbich and S. Dimmeler, "Endothelial progenitor cells: characterization and role in vascular biology, " Circulation Research, vol. 95, no. 4, pp. 343-353, 2004.
116. T. Asahara and A. Kawamoto, "Endothelial progenitor cells for postnatal vasculogenesis, " American Journal of Physiology-Cell Physiology, vol. 287, no. 3, pp. C572-C579, 2004.